by European Society of Cardiology
The European Society of Cardiology brings you the most relevant news in cardiovascular medicine, opinions from leading experts, and insight into the latest developments in our field that really matter. You can also be interested in other ESC podcasts: ESC Cardio Talk, EHRA Cardio Talk, HFA Cardio Talk and much more. Check them out!
Language
🇺🇲
Publishing Since
9/21/2022
See how your podcast performs across key metrics
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
July 9, 2026
<p>Host: Emer Joyce</p> <p>Guests: Marianna Fontana</p> <p>Want to watch that extended interview on the management of heart failure in cardiac amyloidosis, go to: <a href= "https://esc365.escardio.org/event/2551?resource=interview">https://esc365.escardio.org/event/2551?resource=interview</a></p> <p>Want to watch that episode? Go to: <a href= "https://esc365.escardio.org/event/2551">https://esc365.escardio.org/event/2551</a></p> <p> </p> <p><strong>Disclaimer </strong></p> <p>ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding.</p> <p>The programme has not been influenced in any way by its funding partners.</p> <p>This programme is intended for health care professionals only and is to be used for educational purposes.</p> <p>The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.</p> <p>Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.</p> <p>All declarations of interest are listed at the end of the episode.</p> <p>The ESC is not liable for any translated content of this video. The English language always prevails.</p> <p>ESC TV Today uses a range of tools and resources (including AI) to support content production.</p> <p>All content is reviewed and approved by the editorial team.</p> <p>Statements and opinions expressed by guest speakers are their own.</p> <p> </p> <p><strong>Declarations of interests</strong></p> <p>Stephan Achenbach, Yasmina Bououdina and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.</p> <p>Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris.</p> <p>John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI.</p> <p>Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo.</p> <p>David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll.</p> <p>Marianna Fontana has declared to have potential conflicts of interest to report: consultancy for Alnylam, Alexion/Caelum Biosciences, Astra Zeneca, Bridgbio/Eidos, Prothena, Attralus, Intellia Therapeutics, Ionis Pharmaceuticals, Cardior, Lexeo Therapeutics, Janssen Pharmaceuticals, Pfizer, Novo Nordisk, Bayer, Mycardium. Research grants from: Alnylam, Bridgbio, Astra Zeneca, Pfizer. Share options in LexeoTherapeutics and shares in Mycardium.</p> <p>Emer Joyce has declared to have potential conflicts of interest to report: Alnylam, Bayer, Pfizer, Fire-1.</p> <p>Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.</p> <p>Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck.</p> <p>Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.</p> <p>Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.</p>
July 9, 2026
<p>This episode covers:</p> <ul> <li>Cardiology This Week: A concise summary of recent studies</li> <li>AI & digital solutions in emergency medicine</li> <li>Management of heart failure in cardiac amyloidosis</li> <li>Spotlight: Orthodexia-Platypnoea Syndrome</li> </ul> <p>Host: Emer Joyce</p> <p>Guests: Marianna Fontana, Wolf Hautz, Konstantinos Koskinas</p> <p>Want to watch that episode? Go to: <a href= "https://esc365.escardio.org/event/2551">https://esc365.escardio.org/event/2551</a></p> <p>Want to watch that extended interview on the management of heart failure in cardiac amyloidosis, go to: <a href= "https://esc365.escardio.org/event/2551?resource=interview">https://esc365.escardio.org/event/2551?resource=interview</a></p> <p> </p> <p><strong>Disclaimer </strong></p> <p>ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding.</p> <p>The programme has not been influenced in any way by its funding partners.</p> <p>This programme is intended for health care professionals only and is to be used for educational purposes.</p> <p>The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.</p> <p>Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.</p> <p>All declarations of interest are listed at the end of the episode.</p> <p>The ESC is not liable for any translated content of this video. The English language always prevails.</p> <p>ESC TV Today uses a range of tools and resources (including AI) to support content production.</p> <p>All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.</p> <p> </p> <p><strong>Declarations of interests</strong></p> <p>Stephan Achenbach, Yasmina Bououdina, Wolf Hautz and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.</p> <p>Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris.</p> <p>John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. </p> <p>Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo.</p> <p>David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll.</p> <p>Marianna Fontana has declared to have potential conflicts of interest to report: consultancy for Alnylam, Alexion/Caelum Biosciences, Astra Zeneca, Bridgbio/Eidos, Prothena, Attralus, Intellia Therapeutics, Ionis Pharmaceuticals, Cardior, Lexeo Therapeutics, Janssen Pharmaceuticals, Pfizer, Novo Nordisk, Bayer, Mycardium. Research grants from: Alnylam, Bridgbio, Astra Zeneca, Pfizer. Share options in LexeoTherapeutics and shares in Mycardium.</p> <p>Emer Joyce has declared to have potential conflicts of interest to report: Alnylam, Bayer, Pfizer, Fire-1.</p> <p>Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.</p> <p>Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck.</p> <p>Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.</p> <p>Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.</p>
June 25, 2026
<p>Host: Emer Joyce Guest:</p> <p>Lorenz Raeber</p> <p>Want to watch that extended interview on <a href= "https://esc365.escardio.org/event/2558?resource=interview">https://esc365.escardio.org/event/2558?resource=interview</a></p> <p>Go to: Want to watch that episode? Go to: <a href= "https://esc365.escardio.org/event/2558">https://esc365.escardio.org/event/2558</a></p> <p> </p> <p><strong>Disclaimer</strong></p> <p>ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding.</p> <p>The programme has not been influenced in any way by its funding partners.</p> <p>This programme is intended for health care professionals only and is to be used for educational purposes.</p> <p>The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.</p> <p>Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.</p> <p>All declarations of interest are listed at the end of the episode.</p> <p>The ESC is not liable for any translated content of this video. The English language always prevails.</p> <p>ESC TV Today uses a range of tools and resources (including AI) to support content production.</p> <p>All content is reviewed and approved by the editorial team.</p> <p>Statements and opinions expressed by guest speakers are their own.</p> <p> </p> <p><strong>Declarations of interests</strong></p> <p>Stephan Achenbach, Yasmina Bououdina and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.</p> <p>Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris.</p> <p>John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI.</p> <p>Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo.</p> <p>David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll.</p> <p>Emer Joyce has declared to have potential conflicts of interest to report: Alnylam, Bayer, Pfizer, Fire-1.</p> <p>Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.</p> <p>Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck.</p> <p>Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.</p> <p>Lorenz Raeber has declared to have potential conflicts of interest to report: consultation/speaker fees from Abbott, Boston Scientific, Occlutech, and research grants to the institution by Abbott, Heartflow, Novo Nordisk and Heartflow.</p> <p>Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.</p>
Discover related shows you might enjoy
Medscape
American College of Cardiology
CardioNerds
European Society of Cardiology
NEJM Group
JAMA Network
JAMA Network
AccessMedicine
JAMA Network
The Clinical Problem Solvers
The Curious Clinicians
Core IM Team
The Curbsiders Internal Medicine Podcast
European Society of Cardiology
American College of Cardiology
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
The European Society of Cardiology brings you the most relevant news in cardiovascular medicine, opinions from leading experts, and insight into the latest developments in our field that really matter.
You can also be interested in other ESC podcasts: ESC Cardio Talk, EHRA Cardio Talk, HFA Cardio Talk and much more. Check them out!
This podcast updates daily.
This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
No, this podcast does not typically feature guests.
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.